CervoMed Unveils $10 Mln Offering Of Shares; Stock Down

CervoMed announced and priced a 2.5 million-share common stock offering at $4.00 per share, for expected gross proceeds of $10 million. The deal is dilutive to existing shareholders but provides additional capital to fund the clinical-stage biotech's operations and development work. The news is likely to pressure the stock modestly on dilution concerns.

Analysis

CervoMed announced and priced a 2.5 million-share common stock offering at $4.00 per share, for expected gross proceeds of $10 million. The deal is dilutive to existing shareholders but provides additional capital to fund the clinical-stage biotech's operations and development work. The news is likely to pressure the stock modestly on dilution concerns.